Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Bioteknik |
In the press release published earlier today the MAR label was placed by mistake.
Copenhagen, Denmark, January 23, 2024 - Tomorrow, January 24, 2024, is the last day of trading in warrants of series TO2 (the "Warrants"). The exercise period for the Warrants runs up to and including January 26, 2024. One (1) Warrant gives the right to subscribe for one (1) new share in Cessatech. The exercise price is DKK 4.71 per share. Note that Warrants not sold by tomorrow, January 24, 2024, or alternatively used to subscribe for shares no later than on January 26, 2024, expire without compensation to the holder.
Summarised terms for the warrants of series TO2
Exercise period: January 12, 2024 - January 26, 2024.
Issue size: 3,838,110 warrants of series TO2, which entitles to subscription of 3,838,110 shares. If all the warrants are exercised, the Company will receive approximately DKK 18.1 million before issuing costs.
Exercise price: DKK 4.71 per share.
Last day trading warrants: January 24, 2024.
Dilution etc.: If all warrants of series TO2 are exercised the share capital will increase with DKK 766,622 from DKK 2,757,751 to DKK 3,525,373. The dilution at the exercise of all warrants of series TO2 amounts to approximately 21.8% percent of the number of shares and number of votes.
Note that the warrants of series TO2 that are not exercised on January 26, 2024 at the latest or sold on January 24, 2024 at the latest, will expire without compensation to the holder.
How warrants are exercisedNominee-registered warrants (Custody account) - Subscription and payment by the exercise of warrants of series T02 shall be made in accordance with instructions from each nominee. Please contact your nominee for additional information. This should be done well before January 26, 2024, as different nominees have different processing times.
Directly-registered warrants (Securities account) - No issue report nor any instructions regarding payments will be sent out. Subscriptions will be made through simultaneous payment in accordance with the instructions on the application form found on the Company's website.
The warrants will then be replaced by interim shares awaiting registration at the Danish Business Authority.
Advisors
Translution Capital acts as financial advisors to the Company in connection with the warrant exercise. Nordic Issuing is the Company's issuing agent whereas Elmann Law Firm is the Company's legal advisor in connection with the warrant exercise of series T02.